Donor-specific blood transfusions (DST): clinical outcome and immunologic considerations

Transplant Proc. 1992 Aug;24(4):1427-8.
No abstract available

MeSH terms

  • Blood Transfusion*
  • Graft Survival / drug effects
  • HLA Antigens / immunology
  • Haplotypes
  • Histocompatibility
  • Humans
  • Immunosuppression Therapy / methods*
  • Kidney Transplantation / immunology*
  • Lymphocyte Culture Test, Mixed
  • Retrospective Studies
  • T-Lymphocytes, Regulatory / immunology
  • Tissue Donors

Substances

  • HLA Antigens